CCT7P2

Across TCGA pan-cancer cohorts, CCT7P2 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated CCT7P2 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher CCT7P2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated CCT7P2 expression acts as an unfavorable survival marker, although some lineages such as PAAD and LGG show a favorable association.

PAAD, THYM, and ACC are the cancer types where CCT7P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	II,III,IV	0.626	0.381	<.001	87	view →
THYM	OS	Tertile	All	0.817	0.976	<.001	63	view →
ACC	OS	Tertile	All	0.517	0.937	<.001	63	view →
LGG	DFS	Median	All	0.838	0.637	<.001	54	view →
LIHC	OS	Tertile	II,III,IV	0.448	0.679	.002	45	view →
UVM	DFS	Tertile	II,III,IV	0.338	0.672	.010	33	view →
SKCM	DFS	Tertile	III,IV	0.426	0.632	.010	24	view →
KICH	DFS	Tertile	All	0.335	0.887	.004	21	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
LUSC	DFS	Tertile	All	0.812	0.711	.012	18	view →
READ	OS	Tertile	IV	0.289	0.899	<.001	9	view →
BLCA	DFS	Tertile	All	0.415	0.520	.045	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

CCT7P2–PAAD (DFS)

Open the PAAD breakdown →